Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Intrathecal trastuzumab for leptomeningeal metastases

    Intrathecal trastuzumab for leptomeningeal metastases

    FromNeuro-Oncology: The Podcast

    Start listeningView podcast show

    Intrathecal trastuzumab for leptomeningeal metastases

    FromNeuro-Oncology: The Podcast

    ratings:
    Length:
    21 minutes
    Released:
    Aug 11, 2023
    Format:
    Podcast episode

    Description

    Dr. Iyad Alnahhas interviews Drs. Priya Kumthekar and Jeffrey Raizer about their recent manuscript entitled: A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2- positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics", published online in Neuro-Oncology in March 2023.
    Released:
    Aug 11, 2023
    Format:
    Podcast episode

    Titles in the series (79)

    Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.